Effect of guar gum on body weight and serum lipids in hypercholesterolemic females. 1980

J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan

The effect of guar gum (15 g/day) on serum lipids and body weight of middle-aged hypercholesterolemic females was studied in a double-blind controlled trial. No consistent changes were observed in serum cholesterol, triglycerides or HDL cholesterol in patients taking guar gum, placebo or no medication at all. A highly significant decrease in body weight (62.9 +/- 2.1 vs. 60.4 +/- 2.2 kg, p < 0.0005, paired comparison) was seen in subjects receiving guar gum, whereas body weight remained constant in the other two groups. It is concluded that the daily ingestion of 15 g of guar gum results in a permanent weight loss, but does not influence serum lipids in females with hypercholesterolemia.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008351 Mannans Polysaccharides consisting of mannose units. Mannan
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
October 1990, Ancient science of life,
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
November 1981, The American journal of clinical nutrition,
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
July 1984, The British journal of nutrition,
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
January 1991, Arteriosclerosis and thrombosis : a journal of vascular biology,
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
March 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
January 1983, Beitrage zu Infusionstherapie und klinische Ernahrung,
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
May 1975, Lancet (London, England),
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
April 1986, Atherosclerosis,
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
June 2001, The American journal of medicine,
J Tuomilehto, and E Voutilainen, and J Huttunen, and S Vinni, and K Homan
January 1998, Plant foods for human nutrition (Dordrecht, Netherlands),
Copied contents to your clipboard!